Hormone therapy associated with reduced colorectal cancer risk

(American Association for Cancer Research) The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.

source : http://www.eurekalert.org

Related News:

• Insufficiency Fractures After Pelvic Radiotherapy In Patients With Prostate Cancer
• Genetic variations influence statin efficacy for lowering colon cancer risk
• Heart transplant patients face greater risk of skin cancer
• How Cells Protect Themselves From Cancer
• The optimal Rx for pancreatic cancer: Stop it before it starts
• Final-phase trial underway for everolimus in gastric cancer
• Pfizer Hid Evidence That HRT Causes Cancer
• Vitamin D May Help Prevent Colon Cancer
• The Human Brain: Exploring Status Quo Bias
• Treating Back Pain In Blood Marrow Cancer Patients